Founders
Dr. Jeremy Lim
CEO & Co-founder, AMILI

MBBS, MPH, MRCS (Edinburgh), MMed (Surgery), FAMS
  • Former partner at Oliver Wyman's Health and Life Sciences practice in Asia.
  • Director of LIGHT, the global health institute at the NUS School of Public Health.
  • Author of "Myth or Magic: The Singapore Healthcare System".
  • Active in the community through roles in NIHA, HealthServe, and Dover Park Hospice, among others.
Dr. Christopher Ting
Vice Chairman (Group) | Co-founder, AMILI | Executive Director, PAH Australia
  • Co-founder of Pathology Asia
  • Co-founder of Biomark
  • Former CEO of Innovative Diagnostics
  • Founder of Quantum Diagnostics
  • Former CEO of Quest Laboratories and Gribbles Pathology
  • Former Assistant Head (Biomedical Sciences Group) at the Economic Development Board of Singapore
  • Clinically trained
Dr. Jonathan Lee
Gastroenterologist | Microbiome Researcher | Co-founder, AMILI
  • Expertise in IBD, NAFLD, and cancers
  • Passionate about precision gut microbiome research and its clinical applications.
Dr. David Ong
Co-founder, AMILI | Gastroenterologist | Microbiome Researcher
  • Visiting senior consultant at NUH.
  • President of the Gastroenterology Society of Singapore.
  • Established the inflammatory bowel disease unit at NUH and actively advises on pharmaceutical advancements.
Leadership
Manu Swarup
Chief Operating Officer
  • Former roles at Goldman Sachs and IBM.
  • Expertise in startups and corporate innovation.
  • Leadership roles at Amplify Health, Holmusk, and Homage, where he spearheaded chronic disease management programs, expanded digital health solutions across multiple APAC markets, and built strategic partnerships with insurers, governments, and healthcare providers.
Jit Han Tan
Chief Growth Officer
  • Former leadership roles at Google and Airbnb.
  • Specializes in P&L management, strategy, and digital transformation.
  • Focused on healthcare, climate, and agriculture solutions.
Dr. Pijika Watcharapichat
Head of Medical and Clinical Informatics
  • Focuses on clinical translation and machine learning systems in healthcare.
  • Medical Director at EYYD
  • Doctor of Philosophy (PhD) in Large-Scale Machine Learning – Imperial College London (2013–2017)
  • Doctor of Medicine (MD) in Lifestyle Medicine – Ministry of Public Health, Thailand (2023)
  • Postgraduate Certificate in Nutrition Sciences – Stanford University (2022)
  • Master of Science (MSc) in Computing Science – Imperial College London (2011–2013, Distinction)
  • Doctor of Medicine (MD) – Chulalongkorn University (2001–2007, Honours, Elective in Plastic Surgery)
We are dedicated to innovation, trust, and driving progress in gut health research and solutions. Together, we aim to empower healthcare professionals and transform lives through science.